We need to keep supporting this kind of research,” a Connecticut researcher and doctor said. “To see if we replicate these ...

In Friday’s Health headlines, it’s kidney cancer awareness month. As we raise awareness about the disease, a new Yale-led ...

Forget one-size-fits-all cancer treatments — personalization is the future, and it’s already showing promise. In a groundbreaking early-phase trial, a personalized vaccine triggered a powerful immune ...

There could be new hope on for kidney cancer patients. Researchers announced early results of an anti-tumor vaccine for patients with stage 3 or 4 kidney cancer, who face high recurrence risk.

The personalized cancer vaccine trial conducted by Yale University offers promising results for patients with advanced kidney cancer.

A personalized vaccine demonstrated the potential to induce long-lasting immune response among people with advanced kidney ...

A clinical trial demonstrates that personalised cancer vaccines effectively target mutations in high-risk kidney cancer, ...

A team of Yale researchers recently published promising results from a clinical trial testing the effectiveness of a new ...

A clinical trial from Memorial Sloan Kettering Cancer Center looked at the effects of a targeted mRNA vaccine on early-stage ...

There could be new hope on the horizon for kidney cancer patients in the form of an experimental vaccine. Researchers at Dana-Farber Cancer Institute, Harvard Medical School, Yale Cancer Center ...

There could be new hope on the horizon for kidney cancer patients in the form of an experimental vaccine. Researchers at Dana-Farber Cancer Institute, Harvard Medical School, Yale Cancer Center ...